CatalystPit

KURAKura Oncology, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $10.71 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$952.77M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-29 · Powl Brian T. (Chief Commercial Officer) · SELL
  • 2026-09-29 · Leoni Mollie (Chief Medical Officer) · SELL
  • 2026-09-29 · FORD KATHLEEN (Chief Operating Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders239
Shares held101,211,030
Value$1.17B
Percent of shares outstanding113.77%
As of quarter end2026-06-30
RECENT NEWS
  • Caspian Therapeutics and Kura Oncology to host investor call
  • Caspian Therapeutics and Kura Oncology to host investor webcast October 13
  • UBS reiterates Kura Oncology stock rating on strong launch metrics
  • Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • JPMorgan initiates Kura Oncology stock with overweight rating
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Kura Oncology, Inc. (KURA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit